HempNewsBreaks Archive - Page 254 of 262

ThursdayJul 06, 2017 10:21 am

HempNewsBreaks – ABcann Global Corporation (TSXV: ABCN) Included in the Horizons Medical Marijuana Life Sciences ETF

ABcann Global Corporation (TSXV: ABCN) yesterday announced its inclusion in the Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ). The ETF is a first-of-its-kind index offering investors direct exposure to a basket of North American life sciences companies with significant business activities in the medical marijuana sector. “The Horizons ETF represents a new type of investment, a fund that tracks an industry in which there is considerable interest but which had no prior investment vehicle through which investors could gain broad exposure,” Aaron Keay, CEO of ABcann, stated in the news release. “Our inclusion in the ETF represents an important…

FridayJun 30, 2017 2:12 pm

HempNewsBreaks – Player’s Network, Inc. (PNTV) Announces Availability of Green Leaf Farms Rosin Products at Las Vegas Dispensary

Player’s Network, Inc. (OTCQB: PNTV) today announced the availability of its Green Leaf Farms rosin products at the Pisos Dispensary, located just a few miles from the Las Vegas Strip. “This day has been a long time coming. It marks both the end of prohibition and the true beginning of mass distribution for Green Leaf Farms products,” Mark Bradley, CEO of Player’s Network, stated in the news release. “Our products are now available at the Pisos Dispensary in Las Vegas, as well as in top notch dispensaries in Henderson. We are aggressively moving on the opportunities provided by this growing…

FridayJun 30, 2017 11:46 am

HempNewsBreaks – ABcann Global Corporation (TSXV: ABCN) Announces Appointment of Dr. Michael Shannon as Chief Medical Consultant

On Thursday, ABcann Global Corporation (TSXV: ABCN) announced that it has retained the services of Dr. Michael Shannon as its chief medical consultant. Shannon brings decades of health care experience to the ABcann team, including time in both the private and public sectors. Among Shannon’s career highlights, in 1996, he assumed responsibilities within Health Canada for re-organizing the Canadian blood system and the development of a new corporate entity dedicated exclusively to the management of blood services in Canada. In 2000, he entered the private sector, simultaneously directing a phase III clinical trial in Canada, the United States and Great…

FridayJun 30, 2017 11:01 am

HempNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Featured in Benzinga Article Evaluating Potential of Cannabinoids in Treating Alzheimer’s

On Thursday, India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, was featured in an article on Benzinga titled ‘Marijuana Could Help Treat Alzheimer's: Here's How It Would Work’. The article notes that soon after discovering the pathway by which low-dose THC binds to amyloid beta plaques and prevents them from aggregating on neurons, the University of South Florida filed a patent for that mechanism. Notably, IGC announced on June 12 that it had acquired exclusive rights to this patent, titled ‘THC as a Potential Therapeutic Agent for Alzheimer’s Disease’,…

ThursdayJun 29, 2017 3:28 pm

HempNewsBreaks – SinglePoint, Inc. (SING) Enters High-Volume Manufacturing Agreement with Premier Biomedical (BIEI)

Premier Biomedical, Inc. (OTCQB: BIEI), a research-based company focused on the discovery and development of medical treatments for a wide range of diseases, this morning announced that it has reached an agreement with specialized holding company SinglePoint, Inc. (OTC: SING) to manufacture Premier’s new-design CBD Hemp Oil Patch in high volume. “We have been working very hard on making acquisitions and inside sales to boost revenues,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “This new business will contribute significantly to our revenue goals.” Per the update, Premier’s CBD Hemp Oil Skin Patch is expected to be the…

ThursdayJun 29, 2017 12:22 pm

HempNewsBreaks – InMed Pharmaceuticals, Inc. (IMLFF) Poised to Benefit from Scientific Reviews Concerning Medical Efficacy of Cannabinoids

An increasing volume of research demonstrates the medical efficacy of cannabinoids to treat a variety of medical concerns. InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems, currently has two potential blockbuster therapies in development that are undergoing scientific review. “With areas of research in dermatology, ocular indications, pain and inflammation, central nervous system disorders, and respiratory and metabolic diseases, InMed’s current pipeline is targeting unmet medical conditions utilizing disease-specific formulations. InMed’s INM-750 may become the first therapy to modulate disease activity…

ThursdayJun 29, 2017 12:16 pm

HempNewsBreaks – SeeThruEquity Initiates Coverage on Earth Science Tech, Inc. (ETST)

SeeThruEquity has initiated coverage and a price target of $4.12 on Earth Science Tech, Inc. (OTC: ETST). Among other highlights, the analyst noted the company’s strong product pipeline, which includes a series of CBD-based nutraceutical and pharmaceutical products anticipated to be launched in the second quarter of 2017 and early 2018. Additionally, the company’s recent launch of new flavored CBD oil (Orange Blossom), organic chocolate CBD line, and pet CBD is expected to boost revenues for this year. For more information, visit www.earthsciencetech.com About Earth Science Tech, Inc. (ETST) Earth Science Tech provides high quality, purity, and full spectrum High…

WednesdayJun 28, 2017 12:12 pm

HempNewsBreaks – Algae Dynamics Corp. (ADYNF) Targets Nutraceutical Market Leveraging Health and Efficacy Effects of Algae-Cannabis Oils

The nutraceutical industry boasts a diversified playing field, and Canada-based Algae Dynamics Corp. (OTCQB: ADYNF) is taking a unique approach to this burgeoning market, focusing on the development of proprietary research and products that combine the health benefits of botanical oils derived from cannabis and algae. “The original core of the company’s product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed…

TuesdayJun 27, 2017 9:02 am

HempNewsBreaks – SinglePoint, Inc. (SING) Subsidiary Receives Major Purchase Order from Premier Biomedical (BIEI)

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced that its recently-acquired DIGS Hydro subsidiary has received a major purchase order from Premier Biomedical (OTCQB: BIEI). DIGS Hydro has already received the initial payment for this order, with final payment due upon delivery. “This opportunity for both SinglePoint and DIGS Hydro is fantastic,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “We have been working very hard on making acquisitions and inside sales to boost revenues. To have this subsidiary execute on its business plan and generate major revenue for SinglePoint is exactly what we want to…

MondayJun 26, 2017 11:29 am

HempNewsBreaks – 22nd Century Group, Inc. (NYSE: XXII) Added to Russell Microcap® Index

22nd Century Group (NYSE MKT: XXII) this morning announced its inclusion to the Russell Microcap® Index. The one-year membership to the index means the plant biotech company is automatically included in the appropriate growth and value style indexes. “We are pleased to be added to the Russell Microcap Index. Our inclusion will generate further interest in the Company’s stock among those investors in the investment community who may be less familiar with 22nd Century Group,” 22nd Century Group president and CEO Henry Sicignano, III, stated in the news release. Shares of 22nd Century Group are down 2.1% at $1.84, trading…

News and publishing service for hemp related companies

Contact us: 512.354.7000

HempNewsBreaks